Cover Image
Market Research Report

Artificial Intelligence in Healthcare Market: World Market Analysis By Component, Technology, End User, By Region, By Country : Forecast to 2024 -- By End User, By Region, By Country

Published by Azoth Analytics Product code 833095
Published Content info 215 Pages
Delivery time: 2-3 business days
Price
Back to Top
Artificial Intelligence in Healthcare Market: World Market Analysis By Component, Technology, End User, By Region, By Country : Forecast to 2024 -- By End User, By Region, By Country
Published: April 30, 2019 Content info: 215 Pages
Description

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Artificial Intelligence in Healthcare Market. The report analyzes the artificial intelligence in healthcare market, By Component (Hardware, Software and Services), By Technology (Natural Language Processing, Machine Learning and Others), By End User (Healthcare Providers, Pharmaceutical Organizations and Others). The artificial intelligence in healthcare market has been analyzed By Region (North America, Europe, Asia Pacific and Rest of the World) and By Country (U.S, Canada, United Kingdom, Germany, China and India) for the historical period of 2014-2018 and the forecast period of 2019-2024.

According to Azoth Analytics research report "Artificial Intelligence in Healthcare Market: World Market Analysis By Component (Hardware, Software, Services), Technology (Natural Language Processing, Machine Learning, Others), End User (Healthcare Providers, Pharmaceutical Organizations, Others) - 2019 Edition: Opportunities and Forecast (2014-2024) - By Region (North America, Europe, Asia Pacific and Rest of the World), By Country (U.S, Canada, United Kingdom, Germany, China, India)", global market is projected to display a robust growth represented by a CAGR of 50.78% during 2019 - 2024.

Over the past few years, an array of economic, demographic, technological as well as environmental factors have been igniting a digital revolution in the healthcare industry. Increasing investments in research and development projects associated with AI in healthcare by key players including Google, IBM Watson, Intel Corporation, Microsoft Corporation, General Vision, etc., has been pushing the market in the right direction. In this research report, the market is segmented on the basis of artificial intelligence technologies, components as well as end users. On the basis of type of component, software has been dominating the global market, while the segment of artificial intelligence services has been witnessing growth at a noteworthy rate. Amongst the regions, North America accounts for the largest regional share in the Global Artificial Intelligence in Healthcare Market in 2018. However, in the forecast period, the Asia Pacific region is anticipated to advance at the highest pace. Some of the key factors driving the robust growth rate of Asia Pacific region include presence of vast consumer base, significant improvement in medical infrastructure and rapid economic development.

The report titled "Artificial Intelligence in Healthcare Market: World Market Analysis By Component (Hardware, Software, Services), Technology (Natural Language Processing, Machine Learning, Others), End User (Healthcare Providers, Pharmaceutical Organizations, Others) - 2019 Edition: Opportunities and Forecast (2014-2024) - By Region (North America, Europe, Asia Pacific and Rest of the World), By Country (U.S, Canada, United Kingdom, Germany, China, India)" has covered and analyzed the potential of Global Artificial Intelligence in Healthcare Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global artificial intelligence in healthcare market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Artificial Intelligence in Healthcare Market (Actual Period: 2014-2018, Forecast Period: 2019-2024)

  • Global Artificial Intelligence in Healthcare Market - Size, Growth, Forecast
  • By Component (Hardware, Software and Services)
  • By Technology (Natural Language Processing, Machine Learning and Others)
  • By End User (Healthcare Providers, Pharmaceutical Organizations and Others)

Regional Markets - North America, Europe, APAC and Rest of the World (Actual Period: 2014-2018, Forecast Period: 2019-2024)

  • Artificial intelligence in healthcare market - Size, Growth, Forecast
  • By Component (Hardware, Software and Services)
  • By End User (Healthcare Providers, Pharmaceutical Organizations and Others)

Country Analysis - U.S, Canada, United Kingdom, Germany, China, India (Actual Period: 2014-2018, Forecast Period: 2019-2024)

  • Artificial intelligence in healthcare market - Size and Growth

Other Report Highlights

  • Market Dynamics - Drivers and Restraints
  • Market Trends
  • SWOT Analysis
  • Porter Five Force Analysis
  • Competitive Landscape - Recent Developments, Artificial Intelligence in Healthcare Market
  • Policy and Regulatory Landscape
  • Company Analysis - IBM Watson Health, Stryker Corporation, General Vision, NVIDIA Corporation, CloudMedx Inc., Next IT Corp., DEEP Genomics, Microsoft Corporation, General Electric, Google.

Customization of the Report

The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.

Table of Contents

Table of Contents

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Artificial Intelligence in Healthcare Market Outlook

5. Global Artificial Intelligence in Healthcare Market: Growth and Forecast

  • 5.1 By Value (2014-2018)
  • 5.2 By Value (2019-2024)

6. Global Artificial Intelligence in Healthcare Market: Segmental Analysis

  • 6.1 Global Artificial Intelligence in Healthcare Market, By Component:
    • 6.1.1 Global AI Hardware in Healthcare Market, By Value (2014-2018)
    • 6.1.2 Global AI Hardware in Healthcare Market, By Value (2019-2024)
    • 6.1.3 Global AI Software in Healthcare Market, By Value (2014-2018)
    • 6.1.4 Global AI Software in Healthcare Market, By Value (2019-2024)
    • 6.1.5 Global AI Services in Healthcare Market, By Value (2014-2018)
    • 6.1.6 Global AI Services in Healthcare Market, By Value (2019-2024)
  • 6.2 Global Artificial Intelligence in Healthcare Market, By Technology:
    • 6.2.1 Global Natural Language Processing in Healthcare Market, By Value (2014-2018)
    • 6.2.2 Global Natural Language Processing in Healthcare Market, By Value (2019-2024)
    • 6.2.3 Global Machine Learning in Healthcare Market, By Value (2014-2018)
    • 6.2.4 Global Machine Learning in Healthcare Market, By Value (2019-2024)
    • 6.2.5 Other AI Technologies in Healthcare Market, By Value (2014-2018)
    • 6.2.6 Other AI Technologies in Healthcare Market, By Value (2019-2024)
  • 6.3 Global Artificial Intelligence in Healthcare Market, By End User
    • 6.3.1 Global Healthcare Providers in AI Market, By Value (2014-2018)
    • 6.3.2 Global Healthcare Providers in AI Market, By Value (2019-2024)
    • 6.3.3 Global Pharmaceutical Organizations in AI Market, By Value (2014-2019)
    • 6.3.4 Global Pharmaceutical Organizations in AI Market, By Value (2019-2024)
    • 6.3.5 Other Global End Users in Healthcare Market, By Value (2014-2018)
    • 6.3.6 Other Global End Users in Healthcare Market, By Value (2019-2024)

7. Global Artificial Intelligence in Healthcare Market: Regional Analysis

  • 7.1 Global Artificial Intelligence in Healthcare Market Size, By Region : Breakdown (%)
    • 7.1.1 Global Artificial Intelligence in Healthcare Market Size, By Region, 2018 (%)
    • 7.1.2 Global Artificial Intelligence in Healthcare Market Size, By Region, 2024F (%)
  • 7.2 North America Artificial Intelligence in Healthcare Market: Growth and Forecast
    • 7.2.1 By Value (2014-2018)
    • 7.2.2 By Value (2019-2024)
    • 7.2.3 By Component, By Value (2014-2018)
    • 7.2.4 By Component, By Value (2019-2024)
    • 7.2.5 By Technology, By Value (2014-2018)
    • 7.2.6 By Technology, By Value (2019-2024)
  • 7.3 North America Artificial Intelligence in Healthcare Market: Country Analysis (U.S and Canada)
    • 7.3.1 U.S Artificial Intelligence in Healthcare Market, By Value (2014-2018)
    • 7.3.2 U.S Artificial Intelligence in Healthcare Market, By Value (2019-2024)
    • 7.3.3 Canada Artificial Intelligence in Healthcare Market, By Value (2014-2024)
    • 7.3.4 Canada Artificial Intelligence in Healthcare Market, By Value (2014-2024)
  • 7.4 Europe Artificial Intelligence in Healthcare Market: Growth and Forecast
    • 7.4.1 By Value (2014-2018)
    • 7.4.2 By Value (2019-2024)
    • 7.4.3 By Component, By Value (2014-2018)
    • 7.4.4 By Component, By Value (2019-2024)
    • 7.4.5 By Technology, By Value (2014-2018)
    • 7.4.6 By Technology, By Value (2019-2024)
  • 7.5 Europe Artificial Intelligence in Healthcare Market: Country Analysis (Germany and U.K)
    • 7.5.1 Germany Artificial Intelligence in Healthcare Market, By Value (2014-2018)
    • 7.5.2 Germany Artificial Intelligence in Healthcare Market, By Value (2019-2024)
    • 7.5.3 U.K Artificial Intelligence in Healthcare Market, By Value (2014-2018)
    • 7.5.4 U.K Artificial Intelligence in Healthcare Market, By Value (2019-2024)
  • 7.6 APAC Artificial Intelligence in Healthcare Market: Growth and Forecast
    • 7.6.1 By Value (2014-2018)
    • 7.6.2 By Value (2019-2024)
    • 7.6.3 By Component, By Value (2014-2018)
    • 7.6.4 By Component, By Value (2019-2024)
    • 7.6.5 By Technology, By Value (2014-2018)
    • 7.6.6 By Technology, By Value (2019-2024)
  • 7.7 APAC Artificial Intelligence in Healthcare Market: Country Analysis (India and China)
    • 7.7.1 India Artificial Intelligence in Healthcare Market, By Value (2014-2018)
    • 7.7.2 India Artificial Intelligence in Healthcare Market, By Value (2019-2024)
    • 7.7.3 China Artificial Intelligence in Healthcare Market, By Value (2014-2018)
    • 7.7.4 China Artificial Intelligence in Healthcare Market, By Value (2019-2024)
  • 7.8 ROW Artificial Intelligence in Healthcare Market: Growth and Forecast
    • 7.8.1 By Value (2014-2018)
    • 7.8.2 By Value (2019-2024)
    • 7.8.3 By Component, By Value (2014-2018)
    • 7.8.4 By Component, By Value (2019-2024)
    • 7.8.5 By Technology, By Value (2014-2018)
    • 7.8.6 By Technology, By Value (2019-2024)

8. Global Artificial Intelligence in Healthcare Market Dynamics

  • 8.1 Global Artificial Intelligence in Healthcare Market Drivers
  • 8.2 Global Artificial Intelligence in Healthcare Market Restraints

9. Global Artificial Intelligence in Healthcare Market Trends

10. Porter Five Force Analysis

11. SWOT Analysis

12. Competitive Landscape: Recent Developments, Artificial Intelligence in Healthcare Market

13. Policy and Regulatory Landscape

14. Company Profiles

  • 14.1 IBM Watson Health
  • 14.2 Stryker Corporation
  • 14.3 General Vision, Inc.
  • 14.4 NVIDIA Corporation
  • 14.5 CloudMedx Inc.
  • 14.6 DEEP Genomics
  • 14.7 Next IT Corp.
  • 14.8 Microsoft Corporation
  • 14.9 General Electric
  • 14.10 Google

List of Figures

  • Figure 1: Artificial Intelligence in Healthcare Market Segmentation Flowchart
  • Figure 2: Global Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
  • Figure 3: Global Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 4: Projected global population (In Billions)
  • Figure 5: Projected global population aged 60 years & above (In Billions)
  • Figure 6: Distributions of persons aged 60 years or above by region in millions, 2015 and 2030F
  • Figure 7: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
  • Figure 8: Expected Global Medical Spending in 2020, By Region, (% of Total)
  • Figure 9: Regional Expected Healthcare Industry Growth Rate, By Year 2020
  • Figure 10: Top artificial intelligence applications and their estimated potential annual benefits, By 2026
  • Figure 11: Global Prevalence of Different Type of Cancer, 2017 (In Thousands)
  • Figure 12: Global Prevalence of Prostate Cancer (2014-2018, Thousands)
  • Figure 13: Oncologists per 1 Million of Population, By Select Country, 2018
  • Figure 14: Global AI Hardware in Healthcare Market, By Value, 2014-2018 (USD Billion)
  • Figure 15: Global AI Hardware in Healthcare Market, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 16: lobal AI Software in Healthcare Market, By Value, 2014-2018 (USD Billion)
  • Figure 17: Global AI Software in Healthcare Market, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 18: Global AI Services in Healthcare Market, By Value, 2014-2018 (USD Billion)
  • Figure 19: Global AI Services in Healthcare Market, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 20: Global Natural Language Processing in Healthcare Market, By Value, 2014-2018 (USD Billion)
  • Figure 21: Global Natural Language Processing in Healthcare Market, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 22: Global Machine Learning in Healthcare Market, By Value, 2014-2018 (USD Billion)
  • Figure 23: Global Machine Learning in Healthcare Market, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 24: Other Global AI Technologies in Healthcare Market, By Value, 2014-2018 (USD Billion)
  • Figure 25: Other Global AI Technologies in Healthcare Market, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 26: Global Healthcare Providers in AI Market, By Value, 2014-2018 (USD Billion)
  • Figure 27: Global Healthcare Providers in AI Market, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 28: Global Pharmaceutical Organizations in AI Market, By Value, 2014-2018 (USD Billion)
  • Figure 29: Global Pharmaceutical Organizations in AI Market, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 30: Other Global End Users in AI Healthcare Market, By Value, 2014-2018 (USD Billion)
  • Figure 31: Other Global End Users in AI Healthcare Market, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 32: Global Healthcare Landscape, By Select Region
  • Figure 33: Global Artificial Intelligence in Healthcare Market Size, By Region, 2018 (%)
  • Figure 34: Global Artificial Intelligence in Healthcare Market Size, By Region, 2024F (%)
  • Figure 35: North America Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
  • Figure 36: North America Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 37: North America GDP, 2012-2017 (USD Trillion)
  • Figure 38: North America GDP per capita, current prices, 2013-2023F (In USD)
  • Figure 39: Prevalence of Different Type of Cancer in North America in year 2016 & 2017 ( In Hundreds)
  • Figure 40: North America, Cancer Incidence (In Millions)
  • Figure 41: North America, Cancer Incidence, By Technology, 2019E (In %)
  • Figure 42: North America Population above 65 year, 2015, 2030F, & 2050F (In Millions)
  • Figure 43: Most frequent neurological diseases reported in primary care, In North America, 2017 (%)
  • Figure 44: Total Number of People With Cardiovascular Disorders in North America, By Type, 2017 (In thousands)
  • Figure 45: North America Artificial Intelligence in Healthcare Market: By Component, By Value, 2014-2018 (USD Billion)
  • Figure 46: North America Artificial Intelligence in Healthcare Market: By Component, By Value, 2019E-2024F (USD Billion)
  • Figure 47: North America Artificial Intelligence in Healthcare Market: By End User, By Value, 2014-2018 (USD Billion)
  • Figure 48: North America Artificial Intelligence in Healthcare Market: By End User, By Value, 2019E-2024F (USD Billion)
  • Figure 49: U.S. Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
  • Figure 50: U.S. Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 51: U.S Artificial Intelligence Market, Recent Government Initiatives
  • Figure 52: Leading Sites of New Cancer Cases in the United States amongst Males, 2018 (In %)
  • Figure 53: Leading Sites of New Cancer Cases in the United States amongst Females, 2018 (In %)
  • Figure 54: Estimated New Cases of Cancer in the United States, By Type 2018 (In %)
  • Figure 55: Estimated New Cases of Cancer in the United States, 2014-2018 (In Thousands)
  • Figure 56: United States, Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
  • Figure 57: Total Number of People With Cardiovascular Disorders in United States, By Type, 2017 (In thousands)
  • Figure 58: Estimated New Cases of Cancer in the United States, By State, 2018
  • Figure 59: Estimated Numbers of US Cancer Survivors (As of January 1, 2016)
  • Figure 60: Estimated Numbers of US Cancer Survivors (As of January 1, 2026F)
  • Figure 61: Most costly neurological disorders in United States, In 2017
  • Figure 62: U.S., Per Capita Expenditure on Healthcare, 2012-2018 (In USD)
  • Figure 63: Proportion of people with Alzheimer disease, In United States, In 2017
  • Figure 64: Projected number of people with Alzheimer disease aged 65 and older, In United States, In million, In 2017
  • Figure 65: Aggregate cost of care for Alzheimer, By payer, In United States, In 2017
  • Figure 66: Canada Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
  • Figure 67: Canada Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 68: Prevalence of Different Type of Cancer in Canada, 2016 & 2017 ( In Hundreds)
  • Figure 69: Cancer Fact Sheet of Canada, 2017
  • Figure 70: Canada Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
  • Figure 71: Total Number of People With Cardiovascular Disorders in Canada, By Type,2017 (In thousands)
  • Figure 72: Canada, Expenditure on Health as a share of GDP, 2012-2017 (In %)
  • Figure 73: Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD)
  • Figure 74: North America Artificial Intelligence in Healthcare Market, Country Share, 2014-2018 (% of Total)
  • Figure 75: North America Artificial Intelligence in Healthcare Market, Country Share, 2018F-2023F (% of Total)
  • Figure 76: Europe Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
  • Figure 77: Europe Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 78: Europe, Cancer Incidence, 2019E-2035F (In Millions)
  • Figure 79: Europe, Cancer Incidence, By Type, 2019E
  • Figure 80: Prevalence of Different Type of Cancer in Western Europe in year 2016 & 2017 ( In Thousands)
  • Figure 81: Europe, Per Capita Health Expenditure, By Select Country, 2017 (USD)
  • Figure 82: Breakdown of Total Health Expenditure in Europe, 2018 (%)
  • Figure 83: GDP, Europe Region, By Select Country, 2017 (In Trillion USD)
  • Figure 84: Europe Artificial Intelligence Market, Recent Government Initiatives
  • Figure 85: Western Europe Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
  • Figure 86: Total Number of People With Cardiovascular Disorders in Western Europe, By Type, 2017 (In thousands)
  • Figure 87: Europe Artificial Intelligence in Healthcare Market: By Component, By Value, 2014-2018 (USD Billion)
  • Figure 88: Europe Artificial Intelligence in Healthcare Market: By Component, By Value, 2019E-2024F (USD Billion)
  • Figure 89: Europe Artificial Intelligence in Healthcare Market: By End User, By Value, 2014-2018 (USD Billion)
  • Figure 90: Europe Artificial Intelligence in Healthcare Market: By End User, By Value, 2019E-2024F (USD Billion)
  • Figure 91: Germany Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
  • Figure 92: Germany Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 93: Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
  • Figure 94: Germany, Population ages 65 and above, 2012-2017 (% total)
  • Figure 95: Germany, Spending on Healthcare, 2015 & 2040E, (USD Per Person)
  • Figure 96: Germany, Healthcare Related Statistics, 2017
  • Figure 97: Prevalence of Different Type of Cancer in Germany in year 2016 & 2017 ( In Hundreds)
  • Figure 98: Germany Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
  • Figure 99: Total Number of People With Cardiovascular Disorders in Germany, By Type, 2017 (In thousands)
  • Figure 100: U.K. Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
  • Figure 101: U.K. Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 102: Cancer Statistics in the United Kingdom
  • Figure 103: U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
  • Figure 104: U.K Artificial Intelligence Market, Some of the Recent Government Initiatives
  • Figure 105: UK, Healthcare Infrastructure Related Statistics
  • Figure 106: U.K, Population Ages 65 and Above, (% of total), 2012-2017
  • Figure 107: Proportion of people with symptoms of mental disorders in United Kingdom
  • Figure 108: Europe Artificial Intelligence in Healthcare Market, Country Share, Historic, 2014-2018(% of Total)
  • Figure 109: Europe Artificial Intelligence in Healthcare Market, Country Share, Forecast, 2019-2024 (% of Total)
  • Figure 110: APAC Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
  • Figure 111: APAC Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 112: Estimated number of deaths from prostate cancer in 2012 and 2030
  • Figure 113: World health expenditure as % of GDP
  • Figure 114: Population ages 65 and above, APAC Region, By Select Countries, 2017 (% of total)
  • Figure 115: Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total)
  • Figure 116: APAC, GDP, By Select Country, 2017 (In USD Trillion)
  • Figure 117: Most frequent neurological diseases reported in primary care, In Asia Pacific, 2017
  • Figure 118: APAC Artificial Intelligence in Healthcare Market: By Component, By Value, 2014-2018 (USD Billion)
  • Figure 119: APAC Artificial Intelligence in Healthcare Market: By Component, By Value, 2019E-2024F (USD Billion)
  • Figure 120: APAC Artificial Intelligence in Healthcare Market: By End User, By Value, 2014-2018 (USD Billion)
  • Figure 121: APAC Artificial Intelligence in Healthcare Market: By End User, By Value, 2019E-2024F (USD Billion)
  • Figure 122: India Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
  • Figure 123: India Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 124: Key factors affecting the Indian Healthcare Industry
  • Figure 125: India, Total Population, 2013-2023F (In Billion)
  • Figure 126: India, Share of Urban Population, 2012-2017 (In %)
  • Figure 127: India, GDP Growth Per Year, 2015-2019 (In %)
  • Figure 128: India, Total deaths due to cancer, 2018
  • Figure 129: Top 5 forms of cancer in men and women in India
  • Figure 130: China Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
  • Figure 131: China Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 132: China, GDP Growth Per Year, 2015-2019 (In %)
  • Figure 133: China, Share of Urban Population, 2012-2017 (In %)
  • Figure 134: China, Total Population, 2013-2021F (In Billion)
  • Figure 135: Prevalence of Different Type of Cancer in China in year 2016 & 2017 ( In Hundreds)
  • Figure 136: Number of new cases, Males (all ages), 2018 (In %)
  • Figure 137: Number of new cases, Females (all ages), 2018 (In %)
  • Figure 138: China, Cancer Mortality Rate, By Cancer Site, 2018
  • Figure 139: China Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
  • Figure 140: Total Number of People With Cardiovascular Disorders in China, By Type,2017 (In thousands)
  • Figure 141: China Artificial Intelligence Market, Recent Government Initiatives
  • Figure 142: APAC Artificial Intelligence in Healthcare Market, Country Share, Historic, 2014-2018 (% of Total)
  • Figure 143: APAC Artificial Intelligence in Healthcare Market, Country Share, Forecast, 2019-2024 (% of Total)
  • Figure 144: ROW Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
  • Figure 145: ROW Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
  • Figure 146: Middle East and North Africa, GDP, 2012-2017 (In USD Trillion)
  • Figure 147: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %)
  • Figure 148: Prevalence of Different Type of Cancer in Middle East and North Africa in year 2016 & 2017 ( In Hundreds)
  • Figure 149: Prevalence of Different Type of Cancer in Brazil in year 2016 & 2017 ( In Hundreds)
  • Figure 150: ROW Artificial Intelligence in Healthcare Market: By Component, By Value, 2014-2018 (USD Billion)
  • Figure 151: ROW Artificial Intelligence in Healthcare Market: By Component, By Value, 2019E-2024F (USD Billion)
  • Figure 152: ROW Artificial Intelligence in Healthcare Market: By End User, By Value, 2014-2018 (USD Billion)
  • Figure 153: ROW Artificial Intelligence in Healthcare Market: By End User, By Value, 2019E-2024F (USD Billion)
  • Figure 154: Recent Developments, Artificial Intelligence in Healthcare Market
  • Figure 155: Recent Developments, Artificial Intelligence in Healthcare Market
  • Figure 156: Stryker Corporation, Revenue, 2013-2017 (In USD Million)
  • Figure 157: Stryker Corporation, Revenue, By Business Segment, 2017 (In %)
  • Figure 158: Stryker Corporation, Net Sales, By Geographic Region, 2017 (In %)
  • Figure 159: NVIDIA Corporation, Revenue, 2014-2018 (In USD Million)
  • Figure 160: NVIDIA Corporation, Revenue, By Business Segment, 2018 (In %)
  • Figure 161: NVIDIA Corporation, Net Sales, By Geographic Region, 2018 (In %)
  • Figure 162: NVIDIA Corporation, Revenue, By Specialized Market, 2018 (In %)
  • Figure 163: Microsoft Corporation, Revenue, 2014-2018 (In USD Million)
  • Figure 164: Microsoft Corporation, Revenue, By Business Segment, 2018 (In %)
  • Figure 165: Microsoft Corporation, Net Sales, By Geographic Region, 2018 (In %)
  • Figure 166: General Electric, Revenue, 2014-2018 (In USD Billion)
  • Figure 167: General Electric, Revenue, By Business Segment, 2018 (In %)
  • Figure 168: General Electric, Healthcare Segment, Net Sales, By Geographic Region, 2018 (In %)
  • Figure 169: General Electric, Healthcare Sub-Segment Revenue, 2018 (In %)

List of Tables

  • Table A: Recent Company Acquisitions and Mergers in Artificial Intelligence in Healthcare Market
  • Table B: Germany, Healthcare Related Statistics, 2017
  • Table C: Estimated number of people living with cancer, 2020F and 2030F
  • Table D: Global Access to Healthcare Index, Ranking of Select Countries in Asia Pacific Region, 2017 (score out of 10)
  • Table F: India, Cancer Statistics
Back to Top